This is a revised competitive renewal application for an institutional T32, Interdisciplinary Training Program in Lung Disease, submitted under a multiple PI plan that provides the opportunity for exceptional postdoctoral trainees to acquire state-of-the-art knowledge and research skills needed to conduct independent investigation in the pathogenesis and treatment of lung diseases. Centered in the Division of Pulmonary, Allergy and Critical Care Medicine at Duke University, the program is founded on a combined basic and translational science approach and includes both senior and junior faculty preceptors (mentors) from the Departments of Biochemistry, Cell Biology, Immunology, Medicine, Molecular Genetics and Microbiology, Pathology, Pediatrics, Pharmacology and Cancer Biology, and Surgery. For 30 years, the program has been highly successful in placing trainees in academic centers with strong pulmonary research programs and in recruiting minority trainees. The structure of the training program remains intact with three major research training tracks, but it has undergone several changes since the last submission including new program leadership under Drs. Piantadosi and Hogan as well as the recruitment of several new faculty members with expertise in lung development, stem cell biology, asthma, transplant immunology and genetics/genomics. The three major research tracks available to trainees include: Molecular Biology and Cell Signaling in Cardiopulmonary Injury (Track I); Lung Development, Repair, and Regeneration (Track II); and Pulmonary Immunology, Human Genetics, and Lung Disease (Track III). The training program has previously supported 8 postdoctoral (M.D. and/or Ph.D.) trainees annually, but in order to improve our focus and the attention to the needs of each trainee, we are requesting support for two fewer positions (total of 6/year). With the new multiple PI plan, the highly-committed and experienced research track leaders, and the minimization of clinical obligations during the two years of research training, we will provide especially close faculty supervision of the trainees' research progress. Each trainee must establish a mentorship committee comprised of the preceptor plus at least one basic, one clinician-scientist and one junior mentor to guide their progress and to promote their career development well into the junior faculty years. Each trainee also participates in a structured didactic training program that includes formal teaching sessions, weekly divisional and work-in-progress seminars, lectures from distinguished invited speakers, and University course work designed to expand and deepen the their scientific backgrounds. Our goal is to continue to successfully train the next generation of pulmonary scientists by providing each trainee with the research skills necessary to build independent academic careers and to compete for independent research funding in a highly competitive environment.

Public Health Relevance

This is a competitive renewal application for a multidisciplinary T32 training grant in lung disease now in its 29th year. The purpose of the program is to support the recruitment and research training of the most promising M.D. and Ph.D. post-doctoral fellows in lung disease in order to help assure the continuity of highly-qualified, collaborative young scientists who can ably translate new understanding in basic science into the clinical sphere and rapidly advance the diagnosis, prevention and treatment of human lung diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007538-33
Application #
9251306
Study Section
Special Emphasis Panel (NITM (OA))
Program Officer
Colombini-Hatch, Sandra
Project Start
1982-07-01
Project End
2020-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
33
Fiscal Year
2017
Total Cost
$449,509
Indirect Cost
$31,297
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Healy, Zachary R; Murdoch, David M (2016) OMIP-036: Co-inhibitory receptor (immune checkpoint) expression analysis in human T cell subsets. Cytometry A 89:889-892
Durheim, Michael T; Collard, Harold R; Roberts, Rhonda S et al. (2015) Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med 3:388-96
Durheim, Michael T; Smith, Patrick J; Babyak, Michael A et al. (2015) Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Ann Am Thorac Soc 12:349-56
Smith, P J; Rivelli, S K; Waters, A M et al. (2015) Delirium affects length of hospital stay after lung transplantation. J Crit Care 30:126-9
Genao, Liza; Durheim, Michael T; Mi, Xiaojuan et al. (2015) Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc 12:1805-12
Choi, Philip J; Curlin, Farr A; Cox, Christopher E (2015) ""The Patient Is Dying, Please Call the Chaplain"": The Activities of Chaplains in One Medical Center's Intensive Care Units. J Pain Symptom Manage 50:501-6
Smith, Patrick J; Rivelli, Sara; Waters, Alexa et al. (2014) Neurocognitive changes after lung transplantation. Ann Am Thorac Soc 11:1520-7
Blumenthal, James A; Emery, Charles F; Smith, Patrick J et al. (2014) The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study. Psychosom Med 76:581-92
Vickery, Brian P; Scurlock, Amy M; Kulis, Michael et al. (2014) Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 133:468-75
Barkauskas, Christina E; Cronce, Michael J; Rackley, Craig R et al. (2013) Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 123:3025-36

Showing the most recent 10 out of 42 publications